Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10131653
Heterocyclic compound
granted -
US 10125145
5-HT3 receptor antagonists
granted -
US 10112956
Heterocyclic compounds having cholesterol 24-hydroxylase activity
granted -
US 10106556
Heterocyclic compound
granted -
US 10098866
Pharmaceutical preparation containing copolyvidone
granted -
US 10100018
Amide derivatives as lysophosphatidic acid receptor antagonists
granted -
US 10093629
Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
granted -
US 10085986
Pyrimidinone compounds and their use
granted -
US 10087229
Peptide compound
granted -
US 10087150
Heterocyclic compound
granted -
US 10081624
Heterocyclic compound
granted -
US 10077266
Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
granted -
US 10059713
3-substituted 2-amino-indole derivatives
granted -
US 10053468
Heterocyclic compound
granted -
US 10053456
Cyclopropanamine compound and use thereof
granted -
US 10023544
Heterocyclic compound
granted -
US 10017508
Nitrogenated heterocyclic compound
granted -
US 10017487
Fused heterocyclic compound
granted -
US 10017734
Method for producing dopaminergic neurons
granted -
US 10011588
1,2-substituted cyclopentanes as orexin receptor antagonists
granted -
US 10005780
Production method of imidazole derivatives
granted -
US 10004691
Orally disintegrable tablet
granted -
US 10000488
Heterocyclic compound
granted -
US 10000468
Pyrazines as modulators of GPR6
granted